Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Avelumab in Combo w/ Axitinib vs Sunitinib Monotherapy in the First-Line Tx of Pts w/Advnd RCC

Protocol: OSU-15292

Full Title

A Phase III, Multinational, Randomized, Open-Label, Parallelarm Study of Avelumab (Msb0010718c) In Combination with Axitinib (Inlyta®) Versus Sunitinib (Sutent®) Monotherapy in the First-Line Treatment of Patients with Advanced Renal Cell Carcinoma

Kidney Cancer Genitourinary Cancers